首页> 外文期刊>Journal of biomaterials and tissue engineering >MicroRNA-199a Protects Diabetic Retinopathy Under Streptozotocin Conditions by Vascular Endothelial Growth Factor (VEGF)
【24h】

MicroRNA-199a Protects Diabetic Retinopathy Under Streptozotocin Conditions by Vascular Endothelial Growth Factor (VEGF)

机译:microRNA-199A通过血管内皮生长因子(VEGF)保护糖尿病患者在链脲佐菌素条件下保护糖尿病视网膜病变

获取原文
获取原文并翻译 | 示例
           

摘要

Inflammatory stress and angiogenesis participate in diabetic retinopathy. miR-199 alpha( )could inhibit the elevation of wound angiogenesis by suppressing TNF-alpha and NF-kappa B pathway. The mechanism of miR-199a in streptozotocin (STZ)-induced cell damage was assessed by ELLISA kit, western blotting, real-time RT-PCR. Reactive oxygen Species (ROS) was measured by flow cytometry. The over expression of miR-199a decreased the STZ-stimulated oxidative stress, inflammatory response, as well as VEGF expression. In conclusion, our results validated that overexpression of miR-199a protects RMECs from STZ-induced inflammation, oxidative stress and angiogenesis by targeting, at least partly, the VEGF signaling.
机译:炎症胁迫和血管生成参与糖尿病视网膜病变。 MiR-199α()可以通过抑制TNF-α和NF-κB途径来抑制伤口血管生成的升高。 通过Ellisa试剂盒,Western印迹,实时RT-PCR评估MiR-199A在链脲佐菌素(STZ)诱导的细胞损伤中的机制。 通过流式细胞术测量反应性氧物质(ROS)。 miR-199a的过度表达降低了STZ刺激的氧化应激,炎症反应以及VEGF表达。 总之,我们的结果验证了MIR-199A的过度表达通过靶向VEGF信号传导来保护来自STZ诱导的炎症,氧化应激和血管生成的RMEC免受STZ诱导的炎症,氧化应激和血管生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号